Fosun Pharma inks new continuing connected transaction deals

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) has entered into three key continuing connected transactions, effective from November 28, 2025. These include the CQ Pharma Mutual Supply Framework Agreement, Framework Tenancy Agreements (Lessee and Lessor), and the Fosun International Mutual Supply Framework Agreement. The company stated all agreements are on normal commercial terms and considered fair and reasonable by the directors.

The CQ Pharma Mutual Supply Framework Agreement, with CQ Pharma Holdings, is for three years, from January 1, 2026, to December 31, 2028. Total annual caps for sales, purchases, Fosun Pharma services, and CQ Pharma services are RMB1,485m for 2026, RMB1,802m for 2027, and RMB2,122.4m for 2028.

The Framework Tenancy Agreements, involving Fosun International, are for a one-year term from January 1, 2026, to December 31, 2026. The annual cap for the Lessee Framework Agreement is RMB60m, and for the Lessor Framework Agreement, it is RMB8m for the financial year ending December 31, 2026. The Fosun International Mutual Supply Framework Agreement, also with Fosun International, is for one year (January 1, 2026, to December 31, 2026) with an aggregate annual cap of RMB205m for mutual products and services.